However, it should be pointed out that no significant differences between high CHI3L2 and poor prognosis in GBM were achieved in our cohort, which is different from the results (The relationship between high CHI3L2 mRNA expression and short overall survival time were statistically significant in all subgroups) in TCGA and CGGA datasets. This evidence concerns the gene CHI3L2 and glioblastoma.